S&P 500

5.631,22

0,28%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/09/2012	00:30	Business Wire	Spectrum Pharmaceuticals & Allos Therapeutics Announce Expiration of Offering Period & Final Completion of Tender Offer for S...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
31/08/2012	13:50	Zacks	SPPI a Step Closer to Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/08/2012	07:57	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/08/2012	19:46	Business Wire	Spectrum Pharmaceuticals & Allos Therapeutics Announce That FTC Clears Transaction; Tender Offer for Shares of Allos Common S...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/08/2012	07:00	Zacks	Spectrum Extends Allos Buyout Offer - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/08/2012	18:32	Business Wire	Spectrum Pharmaceuticals & Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therap...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/07/2012	10:25	Dow Jones News	US HOT STOCK FUTURES: HOT STOCKS TO WATCH	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/06/2012	06:30	Zacks	Spectrum Extends Allos Tender Offer - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/05/2012	08:00	Business Wire	Spectrum Pharmaceuticals & Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos The...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/05/2012	06:45	Zacks	Allos Narrows Loss, Awaits Takeover - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/05/2012	19:57	Business Wire	Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/04/2012	14:45	Zacks	Bad News for Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/04/2012	10:54	Business Wire	Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/04/2012	09:15	Business Wire	Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/04/2012	09:15	Zacks	Allos Eyed by Spectrum Pharma - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/04/2012	06:06	Zacks	Company News for April 9, 2012 - Corporate Summary	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	15:07	Dow Jones News	UPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 Million	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	11:28	PR Newswire (US)	Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	09:52	PR Newswire (US)	Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	08:00	Business Wire	Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/03/2012	05:14	Zacks	Zacks #1 Rank Additions for Friday - Tale of the Tape	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/03/2012	07:00	Zacks	Allos Upped to Outperform - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/03/2012	05:15	Zacks	Allos Narrows Loss - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/03/2012	18:00	Business Wire	Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/02/2012	11:00	Business Wire	Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/02/2012	15:46	Zacks	ALTH Seeks Review of Folotyn Verdict - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/01/2012	11:30	Business Wire	Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/01/2012	11:00	Business Wire	Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/01/2012	10:00	Zacks	European Setback for Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/01/2012	10:43	Business Wire	Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)